NCT03633513View on ClinicalTrials.gov

Parkinson's Disease Inflammatory Biomarker Profiling

TerminatedOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions
Parkinson Disease
Interventions
DIAGNOSTIC_TEST

LBT-3627

Immunomodulatory agent

DIAGNOSTIC_TEST

Immunological profiling

Comprehensive profiling of inflammatory and anti-inflammatory markers (incl. cellular, molecular) including cellular functional assays

Trial Locations (2)

19104

Corporal Michael J. Crescenz VA Medical Center, Philadelphia

Longevity Biotech, Inc, Philadelphia

Sponsors

Lead Sponsor

Longevity Biotech
All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

collaborator

Corporal Michael J. Crescenz VA Medical Center - Philadelphia

UNKNOWN

lead

Longevity Biotech

INDUSTRY

NCT03633513 - Parkinson's Disease Inflammatory Biomarker Profiling | Biotech Hunter | Biotech Hunter